Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) Notes Payables (2010)

Updated

Analysis

Sangamo Therapeutics (SGMOQ) Notes Payables (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2010 49.12 Mn
API Access

Sangamo Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY